Inflammatory bowel disease in the context of environmental risks: a review

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Chronic non-communicable diseases are the leading pathologies of the 21st century. Prevention and risk verification of chronic non-communicable diseases are among the most urgent tasks for contemporary healthcare.

Inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease, are characterized by a chronic and recurrent course. Inflammatory bowel diseases of unknown etiology are considered to multifactorial, affecting both psychological and social well-being, and significantly reducing patients’ quality of life.

This review aims to explore environmental risks in the development of inflammatory bowel disease, based on the literature. The review was conducted on the materials of Russian and foreign scientometric, abstract, and full-text databases. The period of publications included in the analysis spanned from 1980 to 2023. A total of 44 publications were analyzed.

Current medical practice acknowledges the association of risk factors and the development of multicausal diseases. The probability of disease occurrence is determined by the impact of certain risk factors, with social factors being of particular importance. A combination of factors, including an improved socioeconomic status of newly industrialized countries, which trigger environmental dynamics, increases the risk of inflammatory bowel diseases. The impact of environmental risks may be a potential missing link in understanding the etiology and increasing prevalence of inflammatory bowel diseases in recent years.

Investigating the relationship between environmental factors and inflammatory bowel diseases may improve understanding of the etiopathogenesis, identify strategies for disease prognosis and prevention, and prepare the healthcare system for the growing burden of this group of chronic non-communicable diseases.

Full Text

Restricted Access

About the authors

Vyacheslav A. Dmitriev

Razumovsky Saratov State Medical University

Author for correspondence.
Email: doctordmitriev@gmail.com
ORCID iD: 0009-0007-2180-8817
SPIN-code: 7916-2340

MD, Cand. Sci. (Medicine)

Russian Federation, Saratov

References

  1. Kobyakova OS, Deev IA, Kulikov ES, et al. Chronic non-infectious diseases: the effects of the combined influence of risk factors. Preventive Medicine. 2019;22(2):45–50. (In Russ.) EDN: VZUNCG doi: 10.17116/profmed20192202145
  2. Reshetnikov A, Frolova I, Abaeva O, et al. Accessibility and quality of medical care for patients with chronic noncommunicable diseases during COVID-19 pandemic. NPJ Prim Care Respir Med. 2023;33(1):14. doi: 10.1038/s41533-023-00328-9
  3. Reshetnikov AV, Prisyazhnaya NV, Pavlov SV, et al. Rheumatoid arthritis in the Russian Federation: sociological aspects. Medical Bulletin of the North Caucasus. 2019;14(2):374–376. (In Russ.) EDN: XRPKZM doi: 10.14300/mnnc.2019.14092
  4. Panova LV. Model of social determinants as the basis of multilevel methodology for studying health. St. Petersburg Sociology Today. 2013;1:221–252. (In Russ.) EDN: RTDXSJ
  5. Cherkasova EA, Krom IL, Novichkova IYu. Social determinants of oncologic diseases. Izvestia Saratov University. New series. Series: Sociology. Political science. 2013;13(1):53–56. (In Russ.) EDN: RBOYMB
  6. Zhuzhlova NY, Krom IL, Sazanova GY. Social determinants of arterial hypertension. Psychosomatic and integrative research. 2015;1(2):203. (In Russ.) EDN: XEACGJ
  7. WHO Regional Office for Europe. The European health report 2002. Copenhagen: WHO Regional Publications. European series, No. 97; 2002. 66 p.
  8. Townsend PB, Whitehead M, Davidson N. Inequalities in health: the black report & the health divide (new third edition). Penguin Books Ltd; 1992. 450 p.
  9. Holme I, Helgeland A, Hjermann I, et al. Four-year mortality by some socioeconomic indicators: the Oslo study. J Epidemiol Community Health. 1980;34(1):48–52. doi: 10.1136/jech.34.1.48
  10. Helmert U, Maschewsky-Schneider U, Mielck A, Greiser E. Soziale ungleichheit bei herzinfarkt und schlaganfall in West-Deutschland. Soz Praventivmed. 1993;38(3):123–132. (In Germany) doi: 10.1007/BF01324345
  11. Shilov AM, Avshalumov ASh, Sinitsina EN, Eremina IV. Correction of risk factors in patients with overweight, combined with insulin resistance and arterial hypertension. Russian Medical Journal. 2011;19(13):805–811. EDN: PHFPSG
  12. Namiki M, Kawashima S, Yamashita T, et al. Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice. Atherosclerosis. 2004;172(1):21–29. doi: 10.1016/j.atherosclerosis.2003.08.032
  13. Pautov LS. Risks of deteriorating health and their social determinants. Bulletin of St. Petersburg University. 2009(2–1):151–158. EDN: KVPYTP
  14. Lebedeva-Nesevrya NA. Theory, methodology and practice of analyzing socially determined risks to population health [dissertation abstract]. Perm; 2014. 369 p. EDN: ZPJRUN
  15. Martynenko TS Environmental inequality: modern approaches to conceptualizing the concept. Bulletin of Tomsk State University. Philosophy. Sociology. Political Science. 2020(57):200–214. EDN: VIJPAC doi: 10.17223/1998863X/57/19
  16. European Regional Office WHO. Inequalities in environmental and health conditions in Europe. Evaluation report. Summary. World Health Organization; 2012 [cited 2020 Apr 14]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0006/162528/EH-inequalities-inEurope_ES_Russian.pdf?ua=1
  17. Wang Z, Lu Y, Li L, et al. Relationship between severity of gastrointestinal symptoms and anxiety symptoms in patients with chronic gastrointestinal disease: the mediating role of illness perception. Psychol Res Behav Manag. 2023;16:4921–4933. doi: 10.2147/PRBM.S429132
  18. Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohns Colitis. 2020;14(1):4–22. doi: 10.1093/ecco-jcc/jjz180
  19. Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–670. doi: 10.1093/ecco-jcc/jjx008
  20. Barberio B, Zamani M, Black CJ, et al. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359–370. doi: 10.1016/S2468-1253(21)00014-5
  21. Gao X, Tang Y, Lei N, et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease. Sci Rep. 2021;11(1):1440. doi: 10.1038/s41598-021-81213-8.
  22. Malik TA. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors. Surg Clin North Am. 2015;95(6):1105–1122. doi: 10.1016/j.suc.2015.07.006
  23. Economou M, Pappas G. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14(5):709–720. doi: 10.1002/ibd.20352
  24. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi: 10.1038/nrgastro.2015.150
  25. Bernstein CN, Kraut A, Blanchard JF, et al. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol. 2001;96(7):2117–2125. doi: 10.1111/j.1572-0241.2001.03946.x
  26. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi: 10.1016/S0140-6736(17)32448-0 Erratum in: Lancet. 2020;396(10256):e56. doi: 10.1016/S0140-6736(20)32028-6
  27. Saadh MJ, Pal RS, Arias-Gonzáles JL, et al. Mendelian randomization analysis investigates causal associations between inflammatory bowel diseases and variable risk factors. Nutrients. 2023;15(5):1202. doi: 10.3390/nu15051202
  28. Agrawal M, Jess T. Implications of the changing epidemiology of inflammatory bowel disease in a changing world. United European Gastroenterol J. 2022;10(10):1113–1120. doi: 10.1002/ueg2.12317
  29. Soon IS, Molodecky NA, Rabi DM, et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012;12:51. doi: 10.1186/1471-230X-12-51
  30. Bondarev VP. Social consequences of the interaction of society with the environment (by the example of urbanized areas). Vestnik Moscow State University. Ser. 18. Sociology and Political Science. 2013;(4):119–134. (In Russ.) EDN: RPQBVT
  31. Lovasz BD, Golovics PA, Vegh Z, Lakatos PL. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Dig Liver Dis. 2013;45(4):269–276. doi: 10.1016/j.dld.2012.08.020
  32. Thakur ER, Sansgiry S, Kramer JR, et al. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020;26(9):1423–1428. doi: 10.1093/ibd/izz280
  33. GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. doi: 10.1016/S2468-1253(19)30333-4
  34. Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. 2017;44(4):673–692. doi: 10.1016/j.pop.2017.07.010
  35. Lautenschlager SA, Barry MP, Rogler G, et al. Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study. BMC Gastroenterol. 2023;23(1):71. doi: 10.1186/s12876-023-02692-9.
  36. Rogler G, Zeitz J, Biedermann L. The Search for Causative Environmental Factors in Inflammatory Bowel Disease. Dig Dis. 2016;34(1):48–55. doi: 10.1159/000447283
  37. Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol. 2016;22(27):6296–6317. doi: 10.3748/wjg.v22.i27.6296
  38. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterology. 2014;146(6):1489–1499. doi: 10.1053/j.gastro.2014.02.009.
  39. Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-based differences in incidence of inflammatory bowel diseases — Pooled analysis of population-based studies from western countries. Gastroenterology. 2018;155(4):1079–1089. doi: 10.1053/j.gastro.2018.06.043
  40. Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(8):313–321. doi: 10.1053/j.gastro.2016.10.020
  41. Kåhrström CT, Pariente N, Weiss U. Intestinal microbiota in health and disease. Nature. 2016;535(7610):47. doi: 10.1038/535047a
  42. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–2379. doi: 10.1056/NEJMra1600266
  43. Singh N, Bernstein CN. Environmental risk factors forinflammatory bowel disease. United European Gastroenterol J. 2022;10(10):1047–1053. doi: 10.1002/ueg2.12319
  44. Dutta AK, Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol. 2016;22(3):1088–1100. doi: 10.3748/wjg.v22.i3.1088

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86498 от 11.12.2023 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80649 от 15.03.2021 г.